Table 1.
Overview of study characteristics of the four included trials
| Study ID | Country | Type of comparison | Study setting | Total number of participants randomised | Number of centres | Primary outcome |
|---|---|---|---|---|---|---|
| [15] | USA | 2 mg IV lorazepam versus 5 mg IV diazepam versus IV placebo | Paramedics | 205 | 10a | Termination of status epilepticus by arrival at the emergency department |
| [21] | France |
2.5 g IV levetiracetam plus IV 1 mg clonazepam versus 1 mg IV clonazepam plus IV placebo |
Paramedics | 203 | 39b | Cessation of convulsions within 15 min of study drug administration |
| [23] | USA | 100 mg/min IV phenobarbital plus 40 mg/min IV phenytoin versus 2 mg/min IV diazepam plus 40 mg/min IV phenytoin | Emergency department | 44 | 1 | Cumulative convulsion time |
| [22] | USA | 10 mg IM midazolam versus 4 mg IV lorazepam | Paramedics | 782 | 79c | Seizures terminated without need for rescue therapy before arrival at the emergency department |
IV intravenous; IM intramuscular
a1 physician-staffed base hospital and 9 destination hospitals
b13 emergency medical service centres and 26 hospital departments
c4314 paramedics, 33 emergency medical centres and 79 receiving hospitals